1. Home
  2. COEP vs QUIK Comparison

COEP vs QUIK Comparison

Compare COEP & QUIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COEP
  • QUIK
  • Stock Information
  • Founded
  • COEP 2017
  • QUIK 1988
  • Country
  • COEP United States
  • QUIK United States
  • Employees
  • COEP N/A
  • QUIK N/A
  • Industry
  • COEP Biotechnology: Biological Products (No Diagnostic Substances)
  • QUIK Semiconductors
  • Sector
  • COEP Health Care
  • QUIK Technology
  • Exchange
  • COEP Nasdaq
  • QUIK Nasdaq
  • Market Cap
  • COEP 86.0M
  • QUIK 100.1M
  • IPO Year
  • COEP N/A
  • QUIK 1997
  • Fundamental
  • Price
  • COEP $16.71
  • QUIK $6.58
  • Analyst Decision
  • COEP
  • QUIK Strong Buy
  • Analyst Count
  • COEP 0
  • QUIK 3
  • Target Price
  • COEP N/A
  • QUIK $10.87
  • AVG Volume (30 Days)
  • COEP 63.6K
  • QUIK 168.6K
  • Earning Date
  • COEP 11-12-2025
  • QUIK 11-10-2025
  • Dividend Yield
  • COEP N/A
  • QUIK N/A
  • EPS Growth
  • COEP N/A
  • QUIK N/A
  • EPS
  • COEP N/A
  • QUIK N/A
  • Revenue
  • COEP $263,555.00
  • QUIK $18,359,000.00
  • Revenue This Year
  • COEP N/A
  • QUIK N/A
  • Revenue Next Year
  • COEP N/A
  • QUIK $77.05
  • P/E Ratio
  • COEP N/A
  • QUIK N/A
  • Revenue Growth
  • COEP N/A
  • QUIK N/A
  • 52 Week Low
  • COEP $2.31
  • QUIK $4.26
  • 52 Week High
  • COEP $19.19
  • QUIK $13.36
  • Technical
  • Relative Strength Index (RSI)
  • COEP 58.33
  • QUIK 62.97
  • Support Level
  • COEP $16.00
  • QUIK $5.86
  • Resistance Level
  • COEP $18.15
  • QUIK $6.37
  • Average True Range (ATR)
  • COEP 1.60
  • QUIK 0.39
  • MACD
  • COEP 0.05
  • QUIK 0.06
  • Stochastic Oscillator
  • COEP 61.02
  • QUIK 81.33

About COEP Coeptis Therapeutics Holdings Inc.

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

About QUIK QuickLogic Corporation

QuickLogic Corp provides programmable silicon and software platforms to enable its customers to develop custom hardware products in a fast time-to-market and cost-effective way. QuickLogic is a fabless semiconductor company with a product range: embedded FPGA (eFPGA) intellectual property (IP), low power, multi-core semiconductor system-on-chips (SoCs), discrete FPGAs, and AI software. The full range of platforms, software tools, and eFPGA IP enables the practical and efficient adoption of AI, voice, and sensor processing across Aerospace, and Defense, Consumer/Industrial IoT, and Consumer Electronics markets.

Share on Social Networks: